fior-markets-logo.jpg
Global Clinical Trial Management System Market Is Expected to Reach USD 1458.01 Million by 2028 : Fior Markets
01 nov. 2021 14h00 HE | Fior Markets
Newark, NJ, Nov. 01, 2021 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global clinical trial management system market is expected to grow from USD 543.60 million in 2021 and...
Graphical Research.jpg
Clinical Trial Management System Market Trends 2021 | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
11 oct. 2021 06h00 HE | Graphical Research
Pune, India, Oct. 11, 2021 (GLOBE NEWSWIRE) -- The global clinical trial management system market size is poised to observe substantial growth during the forecast period, as governments are...
22157.jpg
The Worldwide eClinical Solutions Industry is Expected to Reach $15.4 Billion by 2026
30 sept. 2021 07h13 HE | Research and Markets
Dublin, Sept. 30, 2021 (GLOBE NEWSWIRE) -- The "eClinical Solutions Market by Clinical trial phases, Product (CDMS, EDC, CTMS, eCOA, RTSM, ETMF, Analytics, Integration, Safety), Delivery (Web-based,...
Axiom_20Years_Updated logo.jpg
UPDATE -- Axiom Presents "Rare Disease Studies – Using technology to expand the opportunities of enrollment" at Clinical Trials in Rare Diseases Conference 2021
14 sept. 2021 10h20 HE | Axiom Real-Time Metrics Inc
TORONTO, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations,...
Axiom_20Years_Updated logo.jpg
Axiom Presents "Rare Disease Studies – Using technology to expand the opportunities of enrollment" at Clinical Trials in Rare Diseases Conference 2021
13 sept. 2021 10h33 HE | Axiom Real-Time Metrics Inc
TORONTO, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations,...
Axiom_20Years_Updated logo.jpg
Axiom Presents "Unified Platforms: Streamlining your Start-Up and Submission for Expedited Vaccine Trials" at Vaccines Virtual Conference 2021
03 août 2021 10h42 HE | Axiom Real-Time Metrics Inc
TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will...
Axiom_20Years_Updated logo.jpg
Axiom Exhibiting at DIA 2021 Global Annual Meeting and Virtual Conference June 27- July 1, 2021
25 juin 2021 09h44 HE | Axiom Real-Time Metrics Inc
TORONTO, June 25, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), premier provider of unified eClinical solutions and services focused on small-to-medium science organizations, will be...
Axiom_20Years_Updated logo.jpg
Axiom Presents "Unified Platforms: How to Address the Complexity of Oncology Studies to Better Support Your Sites" at Clinical Operations in Oncology Trials 2021
24 juin 2021 10h00 HE | Axiom Real-Time Metrics Inc
TORONTO, June 24, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will...
Axiom_20Years_Updated logo.jpg
Axiom Presents "Case Study for Achieving Full Data Capture in a Pivotal Medical Device Study" at Clinical Trials for Medical Devices Virtual Conference
23 juin 2021 09h56 HE | Axiom Real-Time Metrics Inc
TORONTO, June 23, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will...
Axiom_20Years_Updated logo.jpg
Axiom Presents "Unified Platforms: Realizing the Benefits of Integration in Trial Planning and Execution" at Future Trials Conference: Decentralized, Direct-to-Patient & Virtual Clinical Trials
22 juin 2021 11h52 HE | Axiom Real-Time Metrics Inc
TORONTO, June 22, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will...